Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: Trends in the PSA era

Urology

Volumn 82, Issue 1, 2013, Pages 60-66

  Glass, Allison S ^a   Cowan, Janet E ^a   Fuldeore, Mahesh J ^b   Cooperberg, Matthew R ^a,c   Carroll, Peter R ^a,c   Kenfield, Stacey A ^a   Greene, Kirsten L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BONE SCINTISCANNING; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DIAGNOSTIC IMAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL FUNCTION; URINARY TRACT FUNCTION;

EID: 84879551177     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.01.072     Document Type: Article

References (31)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. V. Narain, M.L. Cher, and D.P. Wood Jr. Prostate cancer diagnosis, staging and survival Cancer Metastasis Rev 21 2002 17 27
3. J.M. Legler, E.J. Feuer, and A.L. Potosky The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States Cancer Causes Control 9 1998 519 527
4. W.J. Catalona, D.S. Smith, and T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
5. W.J. Catalona, J.P. Richie, and F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
6. M.R. Cooperberg, J.M. Broering, P.W. Kantoff, and P.R. Carroll Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 3 Pt 2 2007 S14 S19
7. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
8. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
9. Y. Pardo, F. Guedea, and F. Aguiló Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687 4696
10. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
11. M. Alemozaffar, M.M. Regan, and M.R. Cooperberg Prediction of erectile function following treatment for prostate cancer JAMA 306 2011 1205 1214
12. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
13. K. Chamie, N. Sadetsky, and M.S. Litwin Physician assessment of pretreatment functional status: a process-outcomes link J Urol 185 2011 1229 1233
14. D.P. Lubeck, M.S. Litwin, and J.M. Henning The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the prostate strategic urologic research endeavor Urology 48 1996 773 777
15. M.R. Cooperberg, J.M. Broering, and M.S. Litwin The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry J Urol 171 2004 1393 1401
16. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis J Natl Cancer Inst 101 2009 878 887
17. M.R. Cooperberg, D.J. Pasta, and E.P. Elkin The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 2005 1938 1942
18. M.S. Litwin, R.D. Hays, and A. Fink The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002 1012
19. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
20. K.L. Greene, J.E. Cowan, and M.R. Cooperberg Who is the average patient presenting with prostate cancer? Urology 66 5 Suppl 2005 76 82
21. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, and L.L. Egevad Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists Adv Anat Pathol 13 2006 57 59
22. K.L. Greene, P.C. Albertsen, and R.J. Babaian Prostate specific antigen best practice statement: 2009 update J Urol 182 2009 2232 2241
23. K. Eichler, S. Hempel, and J. Wilby Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review J Urol 175 2006 1605 1612
24. D.W. Lin, M. Porter, and B. Montgomery Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study Cancer 115 2009 2863 2871
25. Y.H. Shao, K. Demissie, and W. Shih Contemporary risk profile of prostate cancer in the United States J Natl Cancer Inst 101 2009 1280 1283
26. L. Budäus, J. Spethmann, and H. Isbarn Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade BJU Int 108 2011 1256 1261
27. A.V. Kindrick, G.D. Grossfeld, and D.M. Stier Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database J Urol 160 6 Pt 1 1998 2102 2106
28. M.R. Cooperberg, D.P. Lubeck, and G.D. Grossfeld Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor J Urol 168 2002 491 495
29. J. Mohler, R.R. Bahnson, and B. Boston NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162 200
30. C.L. Bennett, T. Yang, and R. Nadler Variations in the use of prostate cancer staging tests: results from one NCCN institution Oncology (Williston Park) 11 1997 155 157
31. M.S. Litwin Health related quality of life in older men without prostate cancer J Urol 161 1999 1180 1184